Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease
Condition(s):COVID-19Last Updated:January 21, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):COVID-19Last Updated:January 21, 2022Terminated
Condition(s):COVID-19Last Updated:April 12, 2023Withdrawn
Condition(s):Asthma in ChildrenLast Updated:January 16, 2024Recruiting
Condition(s):Rheumatoid Arthritis; Myositis; Osteoarthritis; Weakness, MuscleLast Updated:January 22, 2024Terminated
Condition(s):PTSD; Post ICU SyndromeLast Updated:April 13, 2021Completed
Condition(s):HealthyLast Updated:August 31, 2021Completed
Condition(s):Sleep Disturbance; Postmenopausal Symptoms; Insulin Sensitivity; Cardiovascular Risk FactorLast Updated:November 16, 2022Completed
Condition(s):Type 2 DiabetesLast Updated:December 4, 2020Completed
Condition(s):Prematurity; Extreme PrematurityLast Updated:March 19, 2024Completed
Condition(s):Intractable Epilepsy; Convulsive SeizuresLast Updated:February 7, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.